Literature DB >> 26112392

Evaluation of Oxygen Supplementation Status as a Risk Factor Associated with the Development of Severe Retinopathy of Prematurity.

Hiroko Enomoto1, Akiko Miki, Wataru Matsumiya, Shigeru Honda.   

Abstract

PURPOSE: The effects of oxygen supplementation status and other clinical risk factors on the development of severe retinopathy of prematurity (ROP) were evaluated.
METHODS: Clinical records of 143 newborn infants with a gestational age of 32 weeks or less were reviewed. Severe ROP was diagnosed when photocoagulation due to progression to stage 3 was identified or when 'plus disease' developed. The factors were evaluated with univariate and multivariate logistic regression analyses between the groups with severe (n = 24) and non-severe (n = 119) ROP.
RESULTS: Gestational age, birth weight, duration of oxygen supplementation, duration of directional positive air pressure and maximum fraction of inspiratory oxygen (FiO2) were significantly associated with severe ROP in the univariate analyses. In the multivariate analysis, a longer duration of oxygen supplementation and a higher maximum FiO2 were revealed as significant risk factors associated with severe ROP.
CONCLUSIONS: Duration of oxygen supplementation and maximum FiO2 required were important factors associated with severe ROP.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26112392     DOI: 10.1159/000433565

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  10 in total

Review 1.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 2.  The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.

Authors:  Shing Chuen Chow; Pun Yuet Lam; Wai Ching Lam; Nicholas Siu Kay Fung
Journal:  Eye (Lond)       Date:  2022-01-11       Impact factor: 4.456

3.  Achieved oxygen saturations and retinopathy of prematurity in extreme preterms.

Authors:  Marie G Gantz; Waldemar A Carlo; Neil N Finer; Wade Rich; Roger G Faix; Bradley A Yoder; Michele C Walsh; Nancy S Newman; Abbott Laptook; Kurt Schibler; Abhik Das; Rosemary D Higgins
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-06-22       Impact factor: 5.747

4.  Risk Factors Associated with Retinopathy of Prematurity in Very and Extremely Preterm Infants.

Authors:  Claudia Ioana Borțea; Florina Stoica; Marioara Boia; Emil Radu Iacob; Mihai Dinu; Roxana Iacob; Daniela Iacob
Journal:  Medicina (Kaunas)       Date:  2021-04-27       Impact factor: 2.430

5.  Risk Factors for Retinopathy of Prematurity in Premature Born Children.

Authors:  Jasmina Alajbegovic-Halimic; Denisa Zvizdic; Emina Alimanovic-Halilovic; Irena Dodik; Sanela Duvnjak
Journal:  Med Arch       Date:  2015-12

6.  Factors Associated with Retinopathy of Prematurity in Hospitalized Preterm Infants in Sanandaj, Iran.

Authors:  Majid Mansouri; Sirous Hemmatpour; Fouzieh Sedighiani; Mojgan Ghamari; Delnia Chavoshi
Journal:  Electron Physician       Date:  2016-09-20

7.  Association between sepsis and retinopathy of prematurity: a systematic review and meta-analysis.

Authors:  Xiaofen Wang; Kun Tang; Ling Chen; Sixiang Cheng; Huilan Xu
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

8.  Commentary: Retinal immaturity at first screening and retinopathy of prematurity: Image-based validation of 1202 eyes of premature infants to predict disease progression.

Authors:  Lingam Gopal
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

9.  Retinopathy of Prematurity and Assisted Reproductive Technology: Is There an Association?

Authors:  Alaa Alsammahi; Ahmed Basheikh
Journal:  Clin Ophthalmol       Date:  2021-01-22

Review 10.  Role of cytokines and treatment algorithms in retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Curr Opin Ophthalmol       Date:  2017-05       Impact factor: 3.761

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.